deltatrials
Completed NA NCT05300984

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

Evaluation of the Anti-aging Efficacy of a Novel Cosmetic Product

Sponsor: Amazentis SA

Conditions Skin Aging
Interventions Topical Cream with 0.5% Active Topical Cream with 1% Active Topical Placebo Cream
Updated 5 times since 2022 Last updated: Apr 5, 2023 Started: Mar 15, 2022 Primary completion: May 10, 2022 Completion: May 16, 2022

Listed as NCT05300984, this NA trial focuses on Skin Aging and remains completed. Sponsored by Amazentis SA, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. May 2023 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2022 — May 2023 [monthly]

    Completed NA

    Status: Recruiting → Completed

  5. Apr 2022 — Jun 2022 [monthly]

    Recruiting NA

    First recorded

Mar 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Amazentis SA
  • proDERM GmbH
Data source: Amazentis SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Schenefeld, Germany